In cancer, it has been recognized that TGF-β is capable of generating senescence either by direct interaction with p16 and p21 [68] or by indirect action due to exacerbated ROS production and DNA damage by the suppression of adenine nucleotide translocate-2 (ANT2) [69,70]. Here, SLC25A5 is linked to cancer.